ARTICLE | Company News
Atrix, Fujisawa submit Aczone NDA
September 1, 2004 7:00 AM UTC
ATRX and co-development partner Fujisawa Healthcare (Deerfield, Ill.) submitted an NDA for Aczone dapsone gel 5% ( Atrisone) to treat acne vulgaris. Aczone uses ATRX's Solvent Microparticle delivery s...